12-Month Patient-Reported Outcomes After Elective Spine Surgery with Substance Screening
| Journal | Neurosurgery |
| Study Type | Cohort |
| Population | Human participants |
This is the first prospective study to objectively track how preoperative substance use—including cannabis—affects spine surgery outcomes over a full year. It provides crucial data for surgical decision-making and patient counseling in an era where cannabis use is increasingly prevalent among surgical candidates.
This prospective cohort study followed 185 adults who underwent urine toxicology screening before elective spine surgery, tracking patient-reported outcomes for 12 months postoperatively. Among participants (mean age 59.5, 57% female), preoperative screening identified 23% marijuana users, 16% alcohol users, and opioid users. Using repeated-measures analysis controlling for demographics and comorbidities, researchers evaluated functional outcomes and pain scores across substance use groups. The study represents the most comprehensive longitudinal assessment to date of objectively-measured preoperative substance use impact on spine surgery recovery.
“What’s particularly valuable here is the objective urine testing rather than self-reported use, which gives us cleaner data on actual cannabis exposure patterns. The 12-month timeline is clinically relevant since that’s when we expect to see meaningful functional recovery plateaus after spine procedures.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Should I screen patients for substance use before elective spine surgery?
Yes, preoperative urine toxicology screening can provide objective data on substance use that patients may not disclose in clinical interviews. This study found that 16% had alcohol use, 23% had marijuana use, and additional patients had opioid use detected through screening, which can inform perioperative planning and risk stratification.
Does preoperative marijuana use affect long-term outcomes after spine surgery?
Based on this 12-month longitudinal study, preoperative marijuana use identified through urine toxicology does not appear to significantly impair patient-reported outcomes at one year post-surgery. The study used validated patient-reported outcome measures and adjusted for multiple confounding factors including age, sex, BMI, and comorbidities.
How should I counsel patients who use cannabis before spine surgery?
Current evidence suggests that preoperative cannabis use may not negatively impact long-term surgical outcomes, though individual patient factors should be considered. Patients should be counseled about potential perioperative interactions and the importance of honest disclosure, while avoiding unnecessary surgical delays based solely on cannabis use.
What is the clinical significance of detecting multiple substances in preoperative screening?
The study evaluated alcohol, marijuana, and opioid use both individually and in combination, providing insights into polysubstance use patterns. Understanding the prevalence and impact of concurrent substance use helps clinicians develop more comprehensive perioperative care plans and set appropriate outcome expectations.
How reliable are patient-reported outcomes in substance-using populations after spine surgery?
This study successfully collected 12-month patient-reported outcome measures through both chart review and phone outreach in a population with documented substance use. The methodology demonstrates that meaningful longitudinal outcome data can be obtained from these patients when appropriate follow-up protocols are implemented.
